Search results
Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in ...
Digital Journal· 4 days ago...CAMBRIDGE, MA / ACCESSWIRE / July 1, 2024 / Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, presented the roll-out and results of its phase 2/3 COVA study...
French election results boost stocks and the euro | CNN Business
CNN.com· 4 days agoFrench stocks and the euro rallied Monday after results from the first round of elections suggested...
Diamcor Receives Final Approval of CND$2,006,300 Financing
Digital Journal· 22 hours agoNM Management Ltd., a private family holding company based in Manitoba, acquired 6,000,000 units of the Offering for a total consideration...